Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.59 |
| ▸ | NPC1 | O15118 | 7/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 3/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP8 | P22894 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12852111 | 1.00 | RAB9A (0.59) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| SCHEMBL3325893 | 0.85 | NPC1 (0.50) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| SCHEMBL21544993 | 0.83 | NPC1 (0.56) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| SCHEMBL11695483 | 0.78 | MAOA (0.65) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| 2-Phenylbenzo[D]Oxazole SCHEMBL5462415 | 0.78 | RAB9A (0.68) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| SCHEMBL9680824 | 0.77 | NPC1 (0.72) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| SCHEMBL1102401 | 0.77 | NPC1 (0.68) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| SCHEMBL31170 | 0.76 | NPC1 (0.81) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| Acetic Acid SCHEMBL9820144 | 0.75 | RAB9A (0.64) | RAB9ANPC1KDM4EALDH1A1HPGD | |
| SCHEMBL24250386 | 0.75 | NPC1 (0.59) | RAB9ANPC1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121611-B1 | UV-filter compounds based on alpha,beta-dihydroxyketones | DSM IP ASSETS BV (NL) | 2015-04-15 | — | — | EP | disclosed |
| US-8278459-B2 | UV-filter compounds | DSM IP ASSETS B.V. (NL) | 2012-10-02 | — | — | US | disclosed |
| US-20100119462-A1 | UV-FILTER COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100119462-A1 | UV-FILTER COMPOUNDS | ERCC4, ERCC5, ERCC1 | RAB9A 1640/4885NPC1 2100/4885KDM4E 1538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.